Provides the executive summary of the 2017 AHA/ACC/HRS guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death.
Guides VA and SCD prevention in current practice; extends prior guidelines by integrating 2017 evidence for clinicians and researchers.
Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.Section numbers pertain to those in the full-text guideline.†ACC/AHA Representative.‡HRS Representative.§ACC/AHA Task Force on Performance Measures
No takes yet. Share an insight, caveat, or question.
Al‐Khatib et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: